Search - tctmd.com

Displaying 181 - 200 of 311

Sort: Relevancy | Date

Presentation TCT 2015

Ischemic Heart Disease and Acute Coronary Syndrome

Presenter: Hugh J. Linnehan, Bernard J. Gersh

October 13, 2015

Presentation TCT 2015

TCT 68: Safety and Efficacy of Stent Retriever for the Management of Acute Ischemic Stroke Comprehensive Review and Meta-analysis

Presenter: Mark C. Bates, Mark H. Wholey, Konstantinos Marmagkiolis

October 13, 2015

Presentation TCT 2015

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Freddy Abnousi

October 13, 2015

Presentation TCT 2015

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Presenter: Sigmund Silber, Philip M. Urban, Sorin J. Brener

October 13, 2015

Presentation TCT 2015

Adjuvant Pharmacotherapy With Ranolazine In Patients With Ischemic Heart Disease

Presenter: Bernard J. Gersh, Stephen D. Wiviott, Giora Weisz

October 13, 2015

Presentation TCT 2015

ALSTER-CERA: Evaluation of NOGA-Guided Intramyocardial Injection of a Long-Acting Erythropoietin Analogue in Patients With Ischemic Cardiomyopathy

Presenter: David P. Faxon, David O. Williams, Martin W Bergmann

October 13, 2015

Presentation TCT 2015

CTSNet Ischemic MR Trial: Implications for Patient Management

Presenter: Michael A. Borger, Vinod H. Thourani

October 13, 2015

Presentation TCT 2015

The Ischemic Continuum: What Is the Significance of a Lower FFR?

Presenter: Justin E. Davies, Bernard De Bruyne, Nils Johnson

October 12, 2015

Presentation TCT 2015

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Presenter: Morton J. Kern, Jan J. Piek, Tim P. van de Hoef

October 12, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Presenter: Kevin J. Beatt, Craig R. Smith, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron

October 11, 2015

Presentation

CHAMPION PHOENIX: Effect of Cangrelor and Access Site on Ischemic and Bleeding Events

Presenter: JA. Gutierrez

October 05, 2015

Presentation

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

Presenter: BM. Everett BM

August 14, 2015

Presentation

STOP HF: Changes in Ventricular Remodeling and Clinical Status During the Year After SDF-1 Gene Therapy in Chronic Ischemic Heart Failure Patients

Presenter: ES. Chung

June 22, 2015

Presentation

Endovascular Therapy for Acute Ischemic Stroke

Presenter: Partha Sardar

June 22, 2015

Presentation Fellows 2015

Rationale for Revascularization in Stable Ischemic Heart Disease

Presenter: Jeffrey W. Moses, Manish A. Parikh, Ajay J. Kirtane

May 16, 2015

Presentation

Thrombectomy Within 8 Hours After Symptom Onset in Ischemic Stroke

Presenter: T.G. Jovin

April 28, 2015

Presentation

Long-term Effects of Ischemic Postconditioning on Clinical Outcomes

Presenter: J-Y Hahn

March 13, 2015

Presentation

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

Presenter: M. Goyal

February 10, 2015

Presentation

Endovascular Therapy for Ischemic Stroke With Perfusion-Imaging Selection

Presenter: B.C.V. Campbell

February 10, 2015

Advertisement

Ischemic Heart Disease and Acute Coronary Syndrome

TCT 68: Safety and Efficacy of Stent Retriever for the Management of Acute Ischemic Stroke Comprehensive Review and Meta-analysis

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Adjuvant Pharmacotherapy With Ranolazine In Patients With Ischemic Heart Disease

ALSTER-CERA: Evaluation of NOGA-Guided Intramyocardial Injection of a Long-Acting Erythropoietin Analogue in Patients With Ischemic Cardiomyopathy

CTSNet Ischemic MR Trial: Implications for Patient Management

The Ischemic Continuum: What Is the Significance of a Lower FFR?

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

CHAMPION PHOENIX: Effect of Cangrelor and Access Site on Ischemic and Bleeding Events

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

STOP HF: Changes in Ventricular Remodeling and Clinical Status During the Year After SDF-1 Gene Therapy in Chronic Ischemic Heart Failure Patients

Endovascular Therapy for Acute Ischemic Stroke

Rationale for Revascularization in Stable Ischemic Heart Disease

Thrombectomy Within 8 Hours After Symptom Onset in Ischemic Stroke

Long-term Effects of Ischemic Postconditioning on Clinical Outcomes

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

Endovascular Therapy for Ischemic Stroke With Perfusion-Imaging Selection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content